IRMD

Q: What is the price of iRadimed (IRMD) today?

The price of iRadimed (IRMD) today is $ 104.29, with return of 99.2% compared to the last year. The price of iRadimed (IRMD) started the year trading around $ 97.28 and today it is at $ 104.29. Follow the real-time price chart, the historical price of iRadimed (IRMD) and international markets.

Q: When does iRadimed (IRMD) pay dividends?

iRadimed (IRMD) did not distribute dividends in the last year.

Q: Is iRadimed (IRMD) worth it?

Currently, iRadimed (IRMD) is priced at $ 104.29, with a P/E of 59.87%, representing a deviation of 3,936% from its historical average P/E. In the last year, the stock showed a variation of 99.2 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 1.14%. The total shareholder return was 99.20%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy iRadimed (IRMD) stock?

Investing in stocks of iRadimed (IRMD) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of iRadimed (IRMD) yield today?

The yield of iRadimed (IRMD) was 6.76% in the last month, 99.20% in the last year and 372.07% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 1.18 in dividends, with a Dividend Yield of 1.14%.If you wanted to buy 100 stocks of iRadimed (IRMD) today, the total investment would be $ 10,429.00, based on the current price of $ 104.29.If past performance were to repeat, the return on your investment would be:In 1 year: $ 20,774.57In 5 years: $ 49,232.18In 10 years: $ 64,355.27It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

iRadimed Corporation

Price

$ 104.29

return (12m)

99.20%

p/e

59.87

p/b

14.22

DIVIDEND YIELD

1.14%

price IRMD

IRMD

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of IRMD

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

6.76%

3 months

12.72%

1 year

99.20%

2 years

154.01%

5 years

372.07%

10 years

517.08%

Fundamentals IRMD

review the fundamentals of iRadimed shares

P/E

59.87

Sector: -2.17 Industry: -5.92

P/S (Price-to-Sales)

16.06

Sector: 2.04 Industry: 3.20

P/B

14.22

Sector: 2.33 Industry: 2.50

DIVIDEND YIELD (DY)

1.14%

Sector: - Industry: -

ROA

20.67%

Sector: -27.04% Industry: -52.76%

ROE

23.76%

Sector: -30.90% Industry: -45.32%

ROIC

42.03%

Sector: -420.29% Industry: -483.92%

NET MARGIN

26.82%

Sector: -28.97% Industry: -34.84%

GROSS MARGIN

76.75%

Sector: 44.33% Industry: 46.29%

OPERATING MARGIN

31.19%

Sector: -24.52% Industry: -30.48%

EV/EBITDA

49.96

Sector: -0.57 Industry: -4.17

EV/EBIT

51.49

Sector: -2.95 Industry: -5.95

PRICE-TO-ASSETS

12.37

Sector: 1.23 Industry: 1.45

BVPS

7.28

Sector: 3.48 Industry: 1.66

EPS

1.73

Sector: -0.89 Industry: -1.30

EQUITY-TO-ASSETS RATIO

0.87

Sector: 0.42 Industry: 0.46

LIABILITIES / ASSETS

0.13

Sector: 0.47 Industry: 0.43

CAGR REVENUE 5 YEARS

14.92%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

19.24%

Sector: - Industry: -

FAIR VALUE OF iRadimed ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

$ 103.74

Fair Value

$ 0.00

Upside Return potential.

-83.77%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals IRMD

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/b	ROE	dy	market cap	net margin
LLY	45.62	39.48	86.53%	0.57%	$ 941.53 B	31.66%
ISRG	62.59	9.96	15.92%	0.00%	$ 178.75 B	28.38%
TMO	29.23	3.66	12.52%	0.33%	$ 195.94 B	15.05%
SNY	13.02	1.41	10.86%	4.55%	$ 118.78 B	18.68%
NVS	22.66	6.81	30.04%	2.34%	$ 316.95 B	24.67%
ABT	31.01	3.95	12.73%	2.06%	$ 202.33 B	14.72%
MDT	27.16	2.55	9.38%	2.90%	$ 125.30 B	13.00%
GSK	15.59	5.57	35.71%	2.82%	$ 118.88 B	17.48%
CVS	57.39	1.35	2.35%	3.33%	$ 101.47 B	0.44%
BSX	39.33	0.00	0.00%	0.00%	$ 113.97 B	14.44%
TMDX	53.82	13.90	25.84%	0.00%	$ 4.94 B	16.20%
HCA	17.80	-43.58	-244.82%	0.54%	$ 120.77 B	8.97%
IDXX	49.59	32.73	65.99%	0.00%	$ 52.54 B	24.62%
RMD	25.12	5.91	23.51%	0.88%	$ 37.33 B	27.53%
DHR	41.21	2.83	6.88%	0.61%	$ 148.92 B	14.71%
INMD	9.23	1.27	13.73%	0.00%	$ 866.25 M	25.32%
FMS	11.89	0.80	6.75%	3.35%	$ 13.42 B	5.02%
PHG	29.32	2.36	8.06%	2.77%	$ 30.42 B	5.07%
SYK	45.72	6.62	14.48%	0.88%	$ 148.40 B	12.92%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

IRMD Historical Dividends

current DY: 1.14%

5-year average DY: 2.07%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividend	02/23/2026	03/06/2026	0,20000000
Dividend	12/17/2025	12/30/2025	0,50000000
Dividend	11/14/2025	11/25/2025	0,17000000
Dividend	08/18/2025	08/28/2025	0,17000000
Dividend	05/20/2025	05/30/2025	0,17000000
Dividend	02/24/2025	03/05/2025	0,17000000
Dividend	11/15/2024	11/25/2024	0,15000000
Dividend	08/20/2024	08/30/2024	0,15000000
Dividend	05/20/2024	05/30/2024	0,15000000
Dividend	12/22/2023	01/12/2024	0,15000000
Dividend	02/13/2023	02/21/2023	1,05000000
Dividend	02/17/2022	02/24/2022	1,00000000

ABOUT THE COMPANY iRadimed

iRadimed Corporation

Average user rating I10

4.0 (5 people)

United States

34 years

Founded: 1992

2014

Time since IPO - 12 years

110

Employees

The Company iRadimed Corporation (United States), is listed on Nasdaq with a market value of $ 1.35 Billion, having an equity of $ 94.62 Millions.

With a total of 110 employees, the company is listed in the sector of Health and categorized in industry of Medical Supplies and Equipment.

In the last 12 months the Company had a revenue of $ 83.81 Millions, which generated a profit in the amount of $ 22.48 Millions.

As for its main indicators, the Company has a P/E ratio of 59.87, a P/BV ratio of 14.22 and in the last 12 months the dividend yield of IRMD was at 1.14%.

The Company is traded internationally through the ticker IRMD.

Market cap

$ 1.35 Billion

Net worth

$ 94.62 Millions

US$ 94,620,000.00

Assets

$ 108.78 Millions

US$ 108,780,000.00

Total Shares Outstanding

13.00 Millions

13,000,000

Average Daily Trading Volume

$ 74.88 Thousand

US$ 74,880.86

Sector

Health

Industry

Medical Supplies and Equipment

IRMD

IRMD revenue and profits

Financial Results IRMD

DRAG THE FRAME TO SEE MORE DATA

IRMD cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/B

0.00

CVS - CVS Health

$ 80.49 30,14% (12M)

P/E

57.39

3.33%

ROE

2.35%

P/B

1.35

CI - Cigna

$ 283.93 --5,67% (12M)

P/E

11.22

2.08%

ROE

0.00%

P/B

0.00

CNC - Centene

$ 43.82 --24,28% (12M)

P/E

-3.31

0.00%

ROE

-33.28%

P/B

1.10

HUM - Humana

$ 181.58 --29,61% (12M)

P/E

17.71

1.86%

ROE

6.95%

P/B

1.23

HCA - HCA Healthcare

$ 541.80 75,21% (12M)

P/E

17.80

0.54%

ROE

-244.82%

P/B

-43.58

LLY - Eli Lilly

$ 1,007.73 9,37% (12M)

P/E

45.62

0.57%

ROE

86.53%

P/B

39.48

NVS - Novartis

$ 164.18 55,52% (12M)

P/E

22.66

2.34%

ROE

30.04%

P/B

6.81